Bevespi Aerosphere 120 inhalations, manufactured by AstraZeneca, contains Glycopyrronium bromide and Formoterol fumarate hydrate. This inhaler is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is supplied as 120 inhalations per 1 kit, with YJ code 2259808G2027.
Bevespi Aerosphere 120 inhalations
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →